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INTRODUCTION
Sp6, a transcription factor of the SP/KLF family,
is one of the key regulators of tooth development.
Loss-of-function studies demonstrated that Sp6 is
required for ameloblast differentiation in tooth devel-
opment ; the deficiency of Sp6 causes tooth anoma-
lies, including supernumerary teeth, enamel defi-
ciency, cusp defects, root formation, and abnormal
dentin structure (1, 2). However, the molecular basis
for Sp6 function remains unclear. To clarify the role
of Sp6, we established a gain-of-function system in
vitro using the rat dental epithelial cells G5, and
found that Sp6 regulates amelogenesis by down-
regulation of the BMP antagonist follistatin (3). Sub-
sequently, we generated Sp6 transgenic rats as an-
other gain-of-function system in vivo and revealed
perturbed morphological and metabolic differentia-
tion of ameloblasts following ectopic Sp6 expression
(4). These data suggested the indispensable role of
Sp6 in tooth development.
Recently, we also demonstrated that a frameshift
mutation in Sp6 , which disrupts the third zinc finger
domain, is responsible for the autosomal recessive
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The nucleotide sequence of promoter and 5end of rat Rock1
has been deposited into GenBank under the accession number
AB861944.
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amelogenesis imperfecta phenotype in AMI rats.
We observed morphological changes of ameloblasts
in Ami/Ami and Wt/Ami incisors (5). However, the
underlying mechanism through which Sp6 muta-
tions lead to abnormal morphology remains unclear.
Concurrently, we investigated the downstream tar-
gets of Sp6 using comparative microarray analyses
and found that Rock1 is upregulated in the presence
of the Sp6 protein (6).
ROCK1 (Rho-associated coiled-coil-forming
kinase 1) is a serine/threonine kinase which is ac-
tivated by the small GTP-binding protein RhoA.
There are two isoforms, ROCK1 and ROCK2, which
share 65% identity in their complete amino acid se-
quences and 92% identity in their kinase domains
(7). However, the previous study showed distinct
roles of ROCK isoforms in the same cells. ROCK1
activity is essential for formation of stress fibers and
focal adhesion, on the other hand, ROCK2 acts as
a counterbalancing regulator of microfilament bun-
dle and focal adhesion sites (8).
During tooth development, ROCK contributes
to the polarity, proliferation, and differentiation of
ameloblasts by regulating actin cytoskeleton organi-
zation and cell-cell adhesion (9). RhoA also regu-
lates the expression of amelogenin and DSPP during
cytodifferentiation of ameloblasts and odontoblasts,
respectively (10). However, the regulation of Rock1
expression has not been investigated, although the
activators of Rock1 have been widely discussed.
In the present study, we demonstrated that Sp6
positively regulates Rock1 expression by direct bind-
ing to the Rock1 promoter. We also observed the
critical elements to affect both Sp6-enhanced Rock1
promoter activity and Sp6 binding to the Rock1 pro-
moter. In addition, we found that Sp1 downregulated
Rock1 transcription. The present data suggest a
unique role of Sp6 in tooth development and mor-
phogenesis that may be essential for future studies
of tooth regeneration.
MATERIALS AND METHODS
Cell Culture
Rat dental epithelia-derived cells, G5 (11) and its
Sp6 -stable transformant, C9 (3), were cultured in a
Dulbecco’s modified Eagle’s medium and Ham’s
F12 medium (D/F12, Nissui, Tokyo, Japan) supple-
mented with 10% fetal bovine serum (FBS ; JRH
Biosciences, Lenexa, KS, USA) incubated at 37
in 5% CO2.
RNA Ligase-Mediated 5-Rapid Amplification of
cDNA Ends (RLM-RACE)
Total RNA was extracted from molars of 7-day-
old stroke-prone spontaneously hypertensive rats
(SHRSP) (5) using the TRI reagent (MRC, Cincin-
nati, OH, USA). RNA was then used in RLM-RACE
assays with a GeneRacer kit (Invitrogen, Carlsbad,
CA, USA), according to the manufacturer’s protocol.
In brief, total RNA was dephosphorylated with calf
intestinal alkaline phosphatase followed by tobacco
acid pyrophosphatase treatment to remove cap
structures from the 5ends of full-length mRNAs.
Oligo RNAs were then added to the 5ends of the
RNA using RNA ligase. Ligated RNAs were reverse
transcribed to cDNAs using oligo dT-primers, and
these cDNAs were then used as templates in PCR
amplification. Initial and nested PCRs were per-
formed using the antisense primers 5-GGGATCC-
CGCAGCAGGTTGTCGA-3and 5-CAAGTTCAA-
CCAACTTCCTCCGCGG-3, respectively. Amplified
products were subcloned into pGEM-T easy plas-
mid vectors (Promega, Madison, WI, USA), and
eleven clones were sequenced.
In Silico Promoter Analysis
Potential transcription factor binding sites were
identified in the 2500-bp region upstream to the
newly identified transcription start site of Rock1
(accession number : AB861944) using the TFBIND
algorithm (http : //tfbind.hgc.jp/). These sites were
confirmed using the GENETYX software program,
version 10 (Genetyx), and overlapping sites that
were identified in the “A” region were used in fur-
ther analyses.
Chromatin Immunoprecipitation (ChIP)-PCR assay
Sp6 binding to the Rock1 promoter in C9 cells
were determined using a ChIP-IT Express Enzy-
matic kit (Active Motif, Carlsbad, CA, USA) with
some modifications. In brief, cells were cross-linked
with 1% formaldehyde for 10 min, harvested on ice,
and were Dounce-homogenized 40 times in ice bath.
DNA-protein complexes were enzymatically di-
gested to the lengths of 200-1000 bp, as determined
by gel electrophoresis. Rabbit IgG antiserum di-
rected against anti-HA high affinity clone 3F10
(Roche, Mannheim, Germany) was used (3 μg of
antisera per sample) to direct chromatin antibody
pull-down at 4overnight in a rotary mixer (NRC-
20D ; Nissin, Tokyo, Japan). Immunoprecipitated
chromatin was treated sequentially with elution
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buffer, reverse cross-linking buffer, and proteinase
K to recover DNA. The primer sequences and PCR
conditions used to amplify chromatin DNA are pre-
sented in Table 1. ChIP assays were performed in
G5 cells cotransfected with pCI-neo mammalian ex-
pression vector (Promega) harboring HA-tagged rat
Sp6 (WT) and pGL3-mutant reporter constructs.
DNA was amplified using forward primers contain-
ing the mutant sequences (in bold) 1 (5-CCTGT-
CCTCCACTAAATTTAAT -3), 2 (5-TCCGACTT-
CTCTTAAACCGAA -3), 3 (5-CGCCCTCCGCC-
TATAAGAAT -3), and 4 (5-GCCTGCCAGGCCC-
AATAAT -3) and the reverse primer 5-TCCTGT-
TCAAACAAACGGGG-3. PCR reactions were per-
formed with 33 cycles of denaturing at 95for 45 s,
annealing at 57for 45 s, and extension at 72
for 20 s.
Plasmid Constructs
Rat genomic DNA template was amplified by PCR
using a PrimeSTAR Max Premix (Takara, Shiga,
Japan) with the forward primer 5-TGGGCACATG-
TTTTCCCATCTGTGGT-3and the reverse primer
5-TCTAAGGCGCTAGCGGCTGTCTAGC-3, which
flanked the Rock1 region (from -2709 to +383). PCR
reactions were performed with 20 cycles of de-
naturing at 98for 10 s, annealing at 55for 5
s, and extension at 72 for 15 s. Nested PCRs
were performed to generate Rock1 promoter 5de-
letion constructs using the reverse primer 5-CCGA-
AGCTTTTATCCGGTCGCTGCTGGGGTTACG-3
and the forward primers Luc#1 5-CTAGAGCTC-
GTCTGAAGAGTTGTGCCTAGCCCTTG-3, Luc#2
5-CTAGAGCTCTGACCTATGATGAAACCCAAG-
GGTTGAT-3, Luc#3 5-CTAGAGCTCCCAGCTC-
AGCCACCAGAGGCTGG-3, and Luc#4 5-CTAG-
AGCTCAGGCGGACATATTAGTCCCTCTGAGC-
3, which yielded varying PCR product lengths.
PCR reactions were performed with 30 cycles of
denaturing at 98for 10 s, annealing at 55for
5 s, and extension at 72for 15 s. For further 5
deletion constructs in region “A”, we used the for-
ward primers Luc#3.1 5-CTAGAGCTCTCCTCC-
ACTGGGTTTCCGACTTCTC-3, Luc#3.2 5-CTA-
GAGCTCTCCGGCTCCGCCTCTCTCCCCTCC-3,
Luc#3.3 5-CTAGAGCTCTCGCGACCCGGCCAG-
CCCCGC-3, Luc#3.4 5-CTAGAGCTCCTGCGTG-
CGCGTGCGCGAGCGCG-3, and Luc#3.5 5-CT-
AGAGCTCGCGCGCCGGCGGTCCCCGTTTG-3,
which yielded varying amplicon lengths. PCR re-
actions were performed with 30 cycles of dena-
turing at 98for 10 s, annealing at 55for 5 s,
and extension at 72for 5 s. Additional SacI and
HindIII restriction sites were incorporated into
forward and reverse primers, respectively, to fa-
cilitate subcloning of amplified fragments. The
PCR fragments and the luciferase reporter vector
pGL3-basic were separately digested with SacI and
HindIII before ligation, and reporter constructs
were sequenced. Sp6 expression vector was de-
scribed previously (3). Sp1 expression vector was
constructed using pCIneo mammalian expression
vector (Promega). In brief, the entire rat Sp1 coding
region was generated by RT-PCR using PrimeSTAR
GXL DNA Polymerase (Takara) from total RNA of
C9 cells (3). FLAG-tag was added at the N-termi-
nus of Sp1 cDNA in the forward primer. The primer
sequences are the follows ; Forward, 5-CCACCA-
TGGACTACAAAGACGATGACGACAAGAGCGA-
CCAAGATCACTCAATGGATG-3(the underlined
region indicates the position of the FLAG-tag se-
quence) ; Reverse, 5-ATCTCAGAAACATTGCCA-
CTGATATTAATG-3.
Site-Directed Mutagenesis
Constructs containing mutant SP1 and AP2 sites
from the Rock1 promoter region ranging from -206
to -150 were prepared using an AMAP Multi Site-Di-
rected Mutagenesis kit (MBL, Woburn, MA, USA),
according to the manufacturer’s protocol. Luc#3
reporter plasmids were used as PCR templates, and
the products were ligated using phosphorylated
Table 1. ChIP-PCR primers
Rock1 Promoter Primer Sequence (5 3) Annealing () Extension (s) Cycles
-249 to +17
(“A” region)
F : CCAGCTCAGCCACCAGAG 58 30 38
R : TCCTGTTCAAACAAACGGGG
-206 to -150 F : GATTATAAAGATGACGATGATAAA 67 15 35
TCCTCCACTGGGTTTCCGACTTCTC
R : TTTATCATCGTCATCTTTATAATCA
CACGGGCGGGGCCTGGCAGG
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primers containing the following mutant sequences
(in bold) : mutation 1, 5-TCCCTGTCCTCCACTA-
AATTTAATACTTCTCTTCGCCCTCC-3; muta-
tion 2, 5-GTTTCCGACTTCTCTTAAACCGAAG-
CCTGCCAGGCCCCG-3; mutation 3, 5-CTTCG-
CCCTCCGCCTATAAGAATCCGCCCGTGTCC-
GGC-3; and mutation 4, 5-CCGCCTGCCAGGC-
CCAATAATTGTCCGGCTCCGCCT-3. Mutant
promoter plasmids were transformed into compe-
tent E. coli JM109 cells after treatment with DpnI
and then sequenced.
Transient Transfection and Dual Luciferase Re-
porter Assay
G5 cells were plated at 6.0104 cells/well in 24-
well plates one day before transfection. Cells were
cotransfected with 400 ng of the pGL3-reporters
pRock1 -Luc or pRock1 -Luc-Mut, 40 ng of pSP6 or
pSP1, and 4 ng of the renilla luciferase reporter plas-
mid pRL-TK using the X-tremeGENE HP DNA
Transfection Reagent (Roche), according to the
manufacturer’s instructions. After 24 h, cell lysates
were prepared, according to the manufacturer’s
protocol, for the Dual Luciferase Reporter Assay
System (Promega), and both firefly and renilla lu-
ciferase activities were measured using a Lumat
LB 9507 (Berthold, Bad Wildbad, Germany). For
the DNA binding inhibitory analysis by mithramycin
A, the cells were cultured with a vehicle (DMSO)
or varying doses of mithramycin A (Sigma, Tokyo,
Japan) 5 h after transfection. The transient transfec-
tion and dual luciferase reporter assay were repeated
at least two times in triplicates. The promoter activ-
ity of each Rock1 promoter construct was measured
by luciferase activity and was normalized by that of
the longest promoter construct without any muta-
tion. For the analysis of the effect of Sp6 on Rock1
promoter activity, the activity was analyzed by com-
paring the luciferase activity of each promoter con-
struct in Sp6 -cotransfected sample with that of the
same construct in pCIneo-cotransfected sample. For
mithramycin A treatment, DMSO was used as con-
trol. The average of control samples is indicated as
100.
Reverse Transcription-PCR (RT-PCR)
G5 cells were plated at 2.88105 cells/well in six-
well plates. The cells were transiently transfected
with the empty pCI-neo, Sp6, or Sp1 expression
vectors and were harvested after 24 h. Total RNA
was extracted using the TRI reagent (MRC), accord-
ing to the manufacturer’s instructions. RNA was
reversed transcribed using an RNA PCR kit AMV
Ver. 3.0 (Takara), according to the manufacturer’s
instructions. Synthesized cDNA was analyzed by
PCR using GoTaq DNA polymerase (Promega) with
the forward primer 5-GGATGCTACCTGATCACC-
AG-3and the reverse primer 5-CCGTAGGCAA-
ACCCGCAAG-3. PCR reactions were performed
with 33 cycles of denaturing at 95for 45 s, anneal-
ing at 57for 45 s, and extension at 72for 30 s.
RT-PCR analysis was performed by three separate
experiments under the same experimental condi-
tions. Expression level of Rock1 mRNA was normal-
ized to that of 18S rRNA.
Statistics
For the luciferase assay, data are meanSD from
at least two separate experiments with triplicate
samples. For RT-PCR analysis, data are meansSD
from three separate experiments (n = 3). Statistical
analysis was performed by Student’s t -test using
Microsoft Excel 2010 software. A p value less than
0.05 was considered to be statistically significant.
RESULTS
Determination of Rock1 Transcription Start Sites
(TSS)
Homology searches of human, mouse, and rat
Rock1 cDNA in GenBank identified 5end struc-
tures with 84% and 96% homology to human and
mouse sequences, respectively, compared with rat
sequence (Fig. 1A). However, TSS of rat Rock1 has
not been identified yet. Therefore, we first per-
formed RLM-RACE to define TSS after removing
the 5-cap structures from intact full-length mRNA
using tobacco acid pyrophosphatase. RLM-RACE
products were then subcloned into the pGEM-T
easy vectors. Based on sequence analyses of 11 ran-
domly picked clones, we identified multiple poten-
tial TSS and defined the most 5end position as +1
(Fig. 1B). Sequencing data from this study have
been deposited into GenBank sequence database
(accession number : AB861944).
Detailed inspections of sequence data revealed
that the rat Rock1 promoter does not contain TATA
or CCAAT boxes, which is in agreement with a re-
port stating that TATA-less promoters often show
multiple TSS (12). Recent bioinformatic analyses
indicated that approximately 76% of human core
promoters lack TATA-like elements, have high GC
contents, and are enriched in SP1-binding sites.
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Moreover, TATA-less genes are frequently involved
in basic “housekeeping” processes, such as protein
biosynthesis, cell growth and/or maintenance, and
intracellular transport (13).
Sp6 Binds to the “A” Region and Positively Regu-
lates Rock1 Promoter Activity
Searches for potential Sp6-binding sites using
TFBIND algorithm on the Rock1 promoter revealed
multiple potential SP1 sites and GC-boxes at around
2,500-bp upstream of TSS. Subsequent in silico
analyses using GENETYX software also identified
five SP1-binding sites and one GC-boxes within
249-bp upstream region of TSS, which overlapped
with TFBIND algorithm finding. Since we did not
find any other sites within 2,500 bp of promoter
region by GENETYX software, we focused on this
249-bp region, named as “A” (Fig. 2A). To define
regulatory regions of the Rock1 promoter, a series
of reporter vectors were constructed with serial de-
letion of Rock1 5-flanking promoter sequences by
inserting at the upstream of the firefly luciferase cod-
ing sequence in the promoter-less plasmid vector,
pGL3-basic (Fig. 2B). Luciferase reporter assays
were then performed to determine the effects of
Sp6 on promoter activity. The Luc#4 reporter con-
struct, which lacked the “A” region, exhibited no
significant promoter activity or enhancement. In con-
trast, Luc#1, Luc#2, and Luc#3 constructs exhibited
higher luciferase activities and were enhanced 1.5-
fold by co-transfection with Sp6 expression plasmids
compared with the control vector (Fig. 2B) indicat-
ing that the “A” region is required for basal activity
and enhancement by Sp6.
To confirm Sp6 binding to the Rock1 promoter
region, we performed ChIP assays using Sp6 -stable
Figure 1. Determination of Rock1 transcription start sites (TSS)
A : The newly identified TSS ; the most 5end of the TSS is indicated with a black arrow at the position +1. Relative positions of the
first nucleotide in human, mouse, and rat Rock1 genes reported in GenBank are shown by vertical lines with their accession numbers.
B : Multiple TSS were determined by RLM-RACE ; denoted as black triangle. TSS is indicated with a black arrow. Asterisk indicates
the position of reported cDNA from rat Rock1 (accession number : NC_005117.2).
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transformant, C9 cells, and anti-HA antibody to pre-
cipitate HA-tagged Sp6 protein followed by PCR us-
ing specific primers for the “A” region. The pre-
dicted 266 bp-band of PCR products was detected,
suggesting the specific binding of Sp6 to the “A” re-
gion (Fig. 2C). Subsequent analyses of endogenous
Rock1 mRNA expression in G5 cells with transient
transfection of Sp6 expression vector were corre-
lated significantly with Sp6-mediated promoter ac-
tivity (p0.001, Fig. 2D).
Sp6 is Functionally Distinct from Sp1
To determine Sp6-binding sites within the “A” re-
gion, we dissected the overlapped SP1 sites and GC-
boxes as shown in Fig. 2A, into several reporter con-
structs (Fig. 3A, Luc#3.1-Luc#3.5), and transiently
cotransfected those reporter constructs and Sp6 or
Sp1 expression vector into G5 cells. Luc #3 and
Luc#3.1 demonstrated the enhancement of promoter
activity by Sp6 at the similar level, however, deletion
of the promoter region from -206 to -150 in Luc#3.2
Figure 2. Sp6 binds to the Rock1 promoter “A” region and enhances its activity
A : Potential Sp6-binding sites identified by in silico analysis. Two results were obtained using TFBIND algorithm and GENETYX soft-
ware, and indicated with symbols above and below the line, respectively, within the 2,500 bp upstream region of TSS. B : Sp6 effect on
Rock1 promoter activity. Left, schematic structure of the serial 5deletion constructs of the Rock1 promoter. Right, luciferase activity
of the desired deletion constructs with empty pCIneo (gray bar) or Sp6 expression vectors (black bar). Figures are representative of
three independent experiments. *** p0.001, **** p0.0001 ; N. S, not significant. C : Detection of Sp6-binding on region “A” by ChIP-
PCR. Chromatin from C9 cells was immunoprecipitated with antibody against HA-tagged Sp6 (Sp6) or non- immune (IgG). PCR prod-
ucts of flanking the “A” region were shown. Input, whole chromatin DNA. D : Sp6 effect on Rock1 mRNA level in G5 cells. Rock1 mRNA
level was normalized by 18S level. pCIneo, transfected with empty vector ; Sp6, transfected with Sp6 expression vectors. *** p0.001.
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resulted in a significant reduction ( p0.0001)
of enhancing activity by Sp6 (Fig. 3B). Since Sp1
binding site is located in this region, it is possible
that Sp6 may compete with Sp1 for binding this
region. Indeed, both Sp1 and Sp6 mRNA are endo-
genously expressed in G5 cells (data not shown).
To assess the effects of Sp1 on these promoter ac-
tivities, we co-transfected with Sp1 expression vec-
tor and reporter plasmids. As shown in Fig. 3C,
Sp1 suppressed Rock1 promoter activity with any
length of promoter, suggesting that Sp6 is function-
ally distinct from Sp1. These results indicated that
Sp6 and Sp1 may positively and negatively regulate
Rock1 promoter activity, respectively. In addition,
we observed the basal activity of Rock1 promoter in
Luc#3.5.
Furthermore, we determined whether mithramy-
cin A, a compound that interferes with Sp1 binding
to GC-rich DNA sequences, affects Rock1 promoter
activity directed by Sp1 or Sp6. Mithramycin A is
frequently used to explore sequence specificities of
DNA-binding factors, and its binding to GC-rich
sequences prevents binding of regulatory proteins
such as Sp1, resulting in inhibition of promoter-de-
pendent transcription in vitro (14). In our study,
treatment with mithramycin A reduced the Sp6-
mediated enhancement of Rock1 promoter activity
in dose-dependent manner, especially up to 200 nM
(Fig. 4A). However, Rock1 promoter repression by
Sp1 was not affected with mithramycin A (Fig. 4B).
Figure 3. Differential regulation of Rock1 promoter activity by Sp1 and Sp6
A : Serial 5deletion constructs of “A” region with indicated consensus binding sites. B and C : Rock1 promoter activity by dual luciferase
reporter assay. G5 cells were transiently cotransfected with the serial 5deletion constructs and either Sp6 (B) or Sp1 (C) expression
vectors using an empty pCIneo vector as a control. Results are expressed as meanSD from three independent experiments (n=9)
or representative experiments (n=3) in B and C, respectively. * p0.05, ** p0.01, *** p0.001, **** p0.0001 when compared with
control (pCIneo) ; p0.0001 when compared Sp6 effect between each construct as indicated by bar ; N. S, not significant.
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As shown in Fig. 4C, Sp6-mediated enhancement of
Rock1 expression was observed at the mRNA level
and the enhancement was abolished in the presence
of mithramycin A. However, in contrast, reduction
of Rock1 expression by Sp1 was not observed at
mRNA level and the Rock1 expression was not af-
fected by mithramycin A treatment.
Determination of Sp6 Responsive Elements
The finding that mithramycin A inhibited the ef-
fects of Sp6 enhancement on the Rock1 promoter
activity with the reporter constructs containing the
region from -206 to -150, prompted us to further
confirm Sp6 responsive elements within this region.
Figure 4. Mithramycin A inhibits Sp6 but not Sp1 function in Rock1 promoter activity
A and B : Effect of mithramycin A on Rock1 promoter activity. G5 cells were transiently cotransfected with Luc#3 reporter construct
and either Sp6 (A) or Sp1 (B) expression vectors using an empty pCIneo vector as a control. Five hours of post- transfection ; cells were
treated with either a vehicle (DMSO) or with varying concentrations of mithramycin A. C : Effect of mithramycin A on Rock1 mRNA ex-
pression. Rock1 mRNA levels were analyzed in G5 cells cotransfected with Sp6 , Sp1 or empty vector, pCIneo with and without mithramycin
A treatment. Results (A and B) are expressed as meanSD from two independent experiments, each in triplicate samples (n=6). * p
0.05, ** p0.01, *** p0.001, **** p0.0001 when compared with control (pCIneo) ; p0.05 when compared with control (DMSO)
treatment ; N. S, not significant.
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Therefore, we performed ChIP assays in G5 cells
using anti-HA antibody to precipitate HA-tagged Sp6
protein and followed by PCR using specific primers
for the region -206 to -150. The specific binding of
Sp6 to the Rock1 promoter region -206 to -150 was
observed as the predicted PCR products (Fig. 5A).
To ensure this result, we mutated the potential SP1
sites that were identified using GENETYX software
for in silico analyses (Fig. 5B). We also mutated
AP2 sites, because AP2 site is GC-rich and the re-
gion from -206 to -150 contains two potential AP2
sites, which may be occupied by Sp6. In addition
Figure 5. Determination of Sp6 responsive elements on Rock1 promoter region
A : Detection of Sp6-binding on region -206 to -150 by ChIP-PCR. G5 cells were transiently cotransfected with the Luc#3.1 reporter and
the Sp6 expression vector. Twenty- four hours of post- transfection ; chromatin from G5 cells was immunoprecipitated using an antibody
against HA-tagged Sp6 (Sp6) or with non- immune (IgG). PCR products with primers flanking the region from -206 to -150 are shown.
Input, whole chromatin DNA. B : Wild-type (WT) and mutant Rock1 promoter sequences (-207 to -150). Top sequence represents the
region from -206 to -150 with indicated TF-binding sites. Mut 1-4 indicated the mutated nucleotides (bold) in this region. Underline,
GCF-binding site. C : Sp6 effect on the luciferase activity of Rock1 mutant promoter constructs. Left, schematic structure of the mutant
constructs of the Rock1 promoter ranging from -206 to -150 ; mut 1-4 indicate mutants 1-4, respectively. Right, luciferase activity of each
mutant construct cotransfected with empty pCIneo (gray bar) or Sp6 expression vector (black bar). Results are expressed as mean
SD from two independent experiments, each in triplicate samples (n=6). * p0.05, ** p0.01, *** p0.001, **** p0.0001 when com-
pared with control (pCIneo) ; p0.001 when compared with the wild type Luc#3 construct ; N. S, not significant. D : Detection of
Sp6-bindings on Rock1 mutant promoter by ChIP-PCR. G5 cells were transiently cotransfected with mutant constructs and Sp6 expres-
sion vectors. Twenty- four hours of post- transfection, chromatin from G5 cells was immunoprecipitated using an antibody against HA-
tagged Sp6 (Sp6) or non- immune (IgG). PCR products are shown. Specific primers for each mutation were synthesized with mutant
nucleotides at the 3end. Input, whole chromatin DNA.
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to the mutations in SP1 and AP2 sites identified by
in silico analyses, we mutated 5-GGGTTTCCG-3
in position number 1 (Fig. 5C) because GGG is a
putative DNA-binding site for Sp1 zinc finger 3 (15).
CCG is the complement sequence of CGG, which
is possibly recognized by Sp1, because mutation of
the 5-GCGGGAGG-3motif in the IER3 promoter
markedly reduces basal and abrogated vorinostat-
induced promoter activity (16). Hence, we have re-
ferred to 5-GGGTTTCCG-3as a putative SP1-bind-
ing site.
As shown in Fig. 5C, mutation of putative SP1-
binding site (Luc#3-mut 1) significantly reduced
Sp6-mediated enhancement of Rock1 promoter ac-
tivity( p0.001), whereas mutation of two AP2
sites, Luc#3-mut-2 and Luc#3-mut-3 constructs,
had no effect on the luciferase activity. Of interest,
while mutation of SP1 site significantly increased ba-
sal activity (p0.0001), Sp6 overexpression had no
effect on promoter activity (Fig. 5C, Luc#3-mut 4).
Next, we found the functional linkage between
Sp6-enhancing effect on Rock1 promoter activity
and Sp6 binding to each mutant construct by ChIP-
PCR analyses (Fig. 5D). We observed that Sp6
could bind to the Luc#3 reporter constructs with
mutated AP2 sites (mut 2 and mut 3) but not with
mutated putative SP1 and SP1 sites (mut 1 and mut
4). These data suggested that two sites containing
GGGtttCCG and CGCCCG motifs in Rock1 promoter
region -206 to -150 are critical for the Sp6-enhanced
expression of Rock1 . Therefore, Sp6 may have bind-
ing selectivity to GC-rich sequences. In addition,
there is another possibility of Sp6 effect to Rock1
promoter activity ; the unknown molecule(s) could
bind to AT-rich sequence of mut1, and recruit Sp6
through protein-protein interaction, resulting in en-
hancement of the promoter activity. However, fur-
ther investigation is necessary to explain the under-
lying mechanism.
DISCUSSION
The present study explored the regulatory mecha-
nisms of Rock1 promoter activity by Sp6, and dem-
onstrated that Sp6 could bind directly to the proxi-
mal 249-bp region of the Rock1 promoter and en-
hanced basal promoter activity. This is the first
report to characterize the effect of Sp6 on Rock1
promoter regulation with its different role from an-
other Sp family member, Sp1.
Distinct regulation by Sp family members is a
quite interesting issue in terms of cell- and tissue-
specificity (17). Nine members in Sp family have
been identified with conserved three zinc finger
DNA binding domains at C-terminus. In addition,
Sp1-4 proteins contain long N-terminal regulatory
domains, but Sp5-9 proteins have shorter N-termi-
nus domains (17, 18). These structural differences
may explain a part of the distinct regulatory function.
Functional promoter analysis using luciferase re-
porter assay indicated that over-expression of Sp6
in G5 cells enhanced Rock1 promoter activity and
endogenous Rock1 mRNA expression (Fig. 2D and
Fig. 4C). However, we observed suppression of
Rock1 promoter activity in the presence of Sp1 (Fig.
3B), and this suppressive effect did not correlate
with endogenous Rock1 mRNA expression (Fig.
4C). Indeed, we only examined the effect of Sp1 on
the “A” region of the Rock1 promoter by in vitro sys-
tem. It remains unclear whether other regions in
Rock1 promoter are involved in Sp1-mediated en-
dogenous promoter activity. Furthermore, we can
measure the steady-state levels of mRNA by RT-
PCR analysis, which are regulated at the transcrip-
tional level and stability in a post-transcriptional
manner (19). The mRNA stability is regulated by
the interaction between cis -acting, i.e. sequence and
structures, and trans -acting factors, i.e. alternative
splicing regulatory factors, turnover and translation
regulator RNA-binding proteins, and non-coding
RNAs (20). It is possible that the post-transcrip-
tional regulator(s) could maintain endogenous Rock1
mRNA level against Sp1-mediated suppression.
Furthermore, we observed that mithramycin A
treatment interfered Sp6-, but not Sp1-mediated
Rock1 promoter activity. These findings did not
show the direct evidence of Sp1- or Sp6- binding to
GC-rich DNA elements on Rock1 promoter region,
but they clearly demonstrated that Sp6-mediated
regulation of Rock1 transcription relies on GC-rich
DNA sequence. It suggested that Sp1 has different
regulatory mechanisms from Sp6, possibly through
the protein-protein interaction with other transcrip-
tion factor(s). This hypothesis may explain that mu-
tated-putative SP1 site did not show any elevation
of basal activity in Figure 5C.
Mutation analysis of Rock1 promoter elements re-
vealed additional interesting findings ; mutation of
known SP1 and putative SP1 sites abolished Sp6-
mediated enhancement of Rock1 promoter activity
and increased basal activity in Luc#3-mut4 con-
struct, respectively (Fig. 5C). The latter finding
raised a question for the underlying mechanisms.
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Since we found Sp1 has suppressive effect in Rock1
promoter, the increased basal activity may simply
occur by abolished endogenous Sp1 binding. How-
ever, we also have to consider the involvement of
other molecules. We observed transient Ap2-over-
expression suppressed Rock1 promoter activity (data
not shown). Ap2 has been shown to bind to not only
the authentic sequence motif 5-GCCN3GGC-3, but
also to the different motifs such as 5-CCCCAGGC-
3in the SV40 enhancer element and E-box site 5-
CACGTG-3in the Myc-response element (21, 22).
Therefore, Ap2 might bind to the region containing
Sp1 site 5-CGCCCG-3to suppress promoter ac-
tivity.
In addition, mutation of SP1 sites might abolish
the suppressive effects of transcriptional repressor
GC-factor (GCF), because the GCF-binding motif
5-GCCCCGC-3was indicated in the Rock1 pro-
moter region from the region of -162 to -156 over-
laps with AP2- and SP1-binding sites by in silico
analysis (Fig. 5B). GCF was originally isolated as a
factor that binds to GC-rich sequences (GCGGG-
GC) and represses transcription of epidermal growth
factor receptor (EGFR ), β-actin , and calcium-de-
pendent protease promoters (23).
The biological role of Sp6-Rock1 axis could be
suggested by their expression patterns and func-
tions. Immunohistochemical analyses demonstrated
that Sp6 and ROCK1 express sequentially (3, 9).
Cytosolic ROCK1 were detected at low level in basal
epithelial cells, inner enamel epithelium cells, and
presecretory ameloblasts (9). Moreover, ROCK1
was strongly expressed in secretory and mature
ameloblasts (9), following the Sp6 expression in the
nuclei of presecretory and secretory ameloblasts (3).
On the other hand, the Rho family inhibitor RhoGDI
was downregulated during ameloblast secretory
stage (24). Interestingly, expression of RhoA, the
direct upstream activator of ROCK, and ROCK1
were also detected strongly in highly polarized
ameloblasts, but weakly in non-polarized cells of in-
ner epithelium and dental papilla during tooth de-
velopment (9, 10).
Rock1 plays pivotal roles in epithelial cell polar-
ity by regulating PAR-1b activity and restricting
basement membrane position (25), supporting that
ROCK1 contributes to the polarity, proliferation,
and differentiation of ameloblasts (9). In agreement
with this, we found that Sp6 regulates ameloblast
morphology and polarity by restoring polarization,
alignment, and height of ameloblasts in Ami/Ami Tg
rats with an Sp6 transgene (5). Taken together, our
findings suggested that Sp6 plays an important role
in amelogenesis by regulating Rock1 expression,
which involved in ameloblasts morphology and po-
larity. Further analyses are required to investigate
the role of Sp6 as a transcription factor during tooth
development and develop the in vivo system for
tooth regeneration.
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